Polypharmacy in Type 2 Diabetes: Appropriate or Cause for Concern?
Diabetes Care
.
2024 Dec 1;47(12):2104-2106.
doi: 10.2337/dci24-0035.
Authors
Zeb I Saeed
1
,
John W Ostrominski
2
,
Vanita R Aroda
1
Affiliations
1
Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
2
Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
PMID:
39602592
DOI:
10.2337/dci24-0035
No abstract available
Publication types
Editorial
Comment